Advances in Health and Disease. Volume 46: Volume 46

This edited volume provides recent updates in the fields of health and disease, including chapters on Noroviruses, fluoride intake, COVID-19 prediction models, type-2 diabetes, gut microbiota, thymol antimicrobial effects, antiphospholipid syndrome thrombotic mechanisms, and thrombocytopenia in COVID-19 patients.

Format: Hardback
Length: 281 pages
Publication date: 20 October 2021
Publisher: Nova Science Publishers Inc

This edited volume presents the most recent advancements in the fields of health and disease. Chapter One delves into the realm of Noroviruses, identifying them as the causative agents behind sporadic infections and widespread epidemic outbreaks of acute gastroenteritis in humans. Chapter Two explores the detrimental effects of fluoride intake, specifically focusing on fluorosis induction and the oxidative stress it induces, both in in vivo and in vitro studies. Chapter Three proposes a comparison of multiple prediction models, including the time series model, to assess their accuracy in forecasting the COVID-19 outbreak. Chapter Four focuses on type-2 diabetes, an immune-metabolic disorder characterized by low-grade inflammation, pancreatic β cell dysfunction, insulin insufficiency, or resistance. Chapter Five delves into the exploration of this immune defect and the development of novel tools for its comprehensive evaluation. Chapter Six unravels the intricate relationship between variations and changes in the composition of the gut microbiota and their impact on normal physiology, contributing to a range of diseases, from inflammation to obesity. Chapter Seven aims to evaluate the available literature regarding the antimicrobial effects of thymol and thymol nanoformulations. It also covers the recent advancements in the applications of thymol as an antimicrobial agent. Chapter Eight provides a clinician's perspective on thrombotic mechanisms in antiphospholipid syndrome, emphasizing the importance of preventive measures and strict control of cardiovascular risk factors, autoimmune diseases, and full thrombophilia screening. Finally, Chapter Nine discusses thrombocytopenia in COVID-19 patients, highlighting its common occurrence.

ISBN-13: 9781685071806